Bridget A. Ross - May 12, 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Nathan Ulrich
Stock symbol
LMAT
Transactions as of
May 12, 2025
Transactions value $
-$199,500
Form type
4
Date filed
5/14/2025, 04:03 PM
Previous filing
Mar 31, 2025
Next filing
Jun 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ross Bridget A Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Nathan Ulrich 2025-05-14 0001698518

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $113K +3.75K +128.6% $30.00 6.67K May 12, 2025 Direct F1
transaction LMAT Common Stock Sale -$312K -3.75K -56.26% $83.20 2.92K May 12, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -3.75K -100% $0.00 0 May 12, 2025 Common Stock 3.75K $30.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $83.20 to $83.21. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 This option is fully vested and exercisable.